Insider · CIK 0001209181

MOMTAZEE JAMES C

Reports to the SEC for 9 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001209181

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+5,054 sh	—	—	111,959
2026-09-16	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,531
2026-09-10	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−2,905 sh	$40.94	−$119K	106,905
2026-07-17	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+405 sh	—	—	109,810
2026-06-22	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+3,990 sh	—	—	19,070
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,277 sh	—	—	5,277
2026-04-17	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+469 sh	—	—	109,499
2026-04-17	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−94 sh	$29.83	−$2,804.02	109,405
2026-01-20	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+609 sh	—	—	109,152
2026-01-20	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−122 sh	$22.98	−$2,803.56	109,030
2025-10-20	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+789 sh	—	—	108,701
2025-10-20	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−158 sh	$17.74	−$2,802.92	108,543
2025-09-10	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+14.5K sh	—	—	111,194
2025-09-10	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−3,282 sh	$13.77	−$45.2K	107,912
2025-09-10	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+33.7K sh	—	—	33,726
2025-07-17	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,201 sh	—	—	96,911
2025-07-17	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−241 sh	$11.65	−$2,807.65	96,670
2025-06-20	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+6,589 sh	—	—	95,080
2025-06-20	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,425 sh	—	—	8,425
2025-04-17	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,379 sh	—	—	95,986
2025-04-17	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−276 sh	$10.15	−$2,801.4	95,710
2025-01-23	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,248 sh	—	—	94,913
2025-01-23	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−306 sh	$11.21	−$3,430.26	94,607
2024-10-21	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,231 sh	—	—	93,665
2024-09-12	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−3,056 sh	$12.12	−$37K	92,434
2024-09-10	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+16.4K sh	—	—	95,490
2024-09-10	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+27.9K sh	—	—	27,894
2024-07-23	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,555 sh	—	—	79,091
2024-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,014
2024-04-24	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,490 sh	—	—	77,829
2024-04-24	ROIVRoivant Sciences Ltd.F Tax Payment	Director	FTax Payment	−293 sh	$10.90	−$3,193.7	77,536
2024-01-19	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,570 sh	—	—	76,339
2023-10-17	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−687 sh	$10.30	−$7,076.1	74,769
2023-09-18	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−6,752 sh	$11.17	−$75.4K	73,862
2023-09-12	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+17.8K sh	—	—	80,614
2023-09-12	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,595
2023-07-03	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,664 sh	—	—	62,789
2023-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.5K sh	—	—	51,501
2023-04-03	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,351 sh	—	—	61,125
2023-01-03	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+2,447 sh	—	—	59,774
2022-10-31	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+3,404 sh	—	—	57,327
2022-10-16	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+1,594 sh	—	—	75,456
2022-09-15	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+50K sh	—	—	53,923
2022-09-15	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+68.9K sh	—	—	68,897
2022-07-20	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+3,923 sh	—	—	3,923
2022-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,921
2021-12-29	BBIOBridgeBio Pharma, Inc.P Purchase	Director	PPurchase	+80K sh	$14.50	+$1.16M	88,491
2021-07-01	PRA Health Sciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,521 sh	—	—	0
2021-06-17	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+38.9K sh	—	—	38,895
2021-06-01	PRA Health Sciences, Inc.A Award	Director	AAward	+330 sh	—	—	3,521

Recent filings

Accepted (ET)
Sep 184
MOMTAZEE JAMES C0001209181-26-000007
SEC(opens sec.gov)
Sep 144
MOMTAZEE JAMES C0001209181-26-000005
SEC(opens sec.gov)
Jul 214
MOMTAZEE JAMES C0001140361-26-029193
SEC(opens sec.gov)
Jun 244
MOMTAZEE JAMES C0001470831-26-000628
SEC(opens sec.gov)
Apr 214
MOMTAZEE JAMES C0001209181-26-000003
SEC(opens sec.gov)
Jan 224
MOMTAZEE JAMES C0001140361-26-002087
SEC(opens sec.gov)
Oct 224
MOMTAZEE JAMES C0001140361-25-038996
SEC(opens sec.gov)
Sep 124
MOMTAZEE JAMES C0001140361-25-034930
SEC(opens sec.gov)
Jul 214
MOMTAZEE JAMES C0001140361-25-026648
SEC(opens sec.gov)
Jun 244
MOMTAZEE JAMES C0000950170-25-089652
SEC(opens sec.gov)
Apr 214
MOMTAZEE JAMES C0001140361-25-014801
SEC(opens sec.gov)

Companies

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, SW1H 0DB